About Krankenhaus der Stadt Linz
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Arbeitsgemeinschaft medikamentoese Tumortherapie
8
Biotronik SE & Co. KG
2
Biotronik Vertriebs-GmbH
1
IHF GmbH - Institut für Herzinfarktforschung
1
Clinical Trials at Krankenhaus der Stadt Linz
During the past decade, Krankenhaus der Stadt Linz conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Closed Loop Stimulation, Cognitive Performance, and Quality of Life in Pacemaker Patients
2006-05-01
2011-03-01
Completed
405
A Multicentre, Randomized Phase III Study of Rituximab as Maintenance Treatment Versus Observation in Patients With Aggressive B-cell Lymphoma: NHL-13
2006-01-01
2013-03-01
Completed
683
A Pilot Trial With Subcutaneous Alemtuzumab and Oral Fludarabinephosphate for the Determination of Safety, Efficacy and Molecular Profiling for the Prediction of Response
2004-03-01
2008-02-13
Completed
10
Multicentre Study to Determine the Cardiotoxicity of R-CHOP Compared to R-COMP in Patients With Diffuse Large B-Cell Lymphoma
2007-12-01
2012-01-01
Completed
94
Survival of Patients With Primary Prophylactic ICD Indication
2008-02-01
2014-07-01
Completed
504
Rituximab Plus 2CdA in Patients With Advanced or Relapsed Mucosa Associated Lymphoid Tissue (MALT) Lymphoma
2008-05-01
2011-09-01
Completed
40
Lenalidomide Dose Escalation Combined With Rituximab/Fludarabine in Untreated CLL
2008-10-01
2012-01-01
Completed
45
Bendamustine Combined With Alemtuzumab in Pretreated Chronic Lymphocytic Leukemia (CLL)
2009-03-01
2012-08-06
Completed
20
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Krankenhaus der Stadt Linz"
#1 collaborator was "Celgene Corporation" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "Roche Pharma AG" with 2 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator and "Lipomed" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were
collaborators in the rest 10 trials.
Clinical Trials Conditions at Krankenhaus der Stadt Linz
According to Clinical.Site data, the most researched conditions in "Krankenhaus der Stadt Linz" are
"Leukemia, Lymphocytic, Chronic, B-Cell" (2 trials), "B-cell Chronic Lymphocytic Leukemia" (1 trials), "Cardiac Pacing, Artificial" (1 trials), "Coronary Artery Disease" (1 trials) and "Coronary Artery Stenosis" (1 trials). Many other conditions were trialed in "Krankenhaus der Stadt Linz" in a lesser frequency.
Clinical Trials Intervention Types at Krankenhaus der Stadt Linz
Most popular intervention types in "Krankenhaus der Stadt Linz" are "Drug" (8 trials), "Device" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Rituximab" (4 trials), "Alemtuzumab" (2 trials), "2-CdA" (1 trials), "ABSORB Scaffold" (1 trials) and "Bendamustine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Krankenhaus der Stadt Linz
The vast majority of trials in "Krankenhaus der Stadt Linz" are
12 trials for "All" genders.
Clinical Trials Status at Krankenhaus der Stadt Linz
Currently, there are NaN active trials in "Krankenhaus der Stadt Linz".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 11 completed trials in Krankenhaus der Stadt Linz,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Krankenhaus der Stadt Linz, 3 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".